Homepage
Summit Details
Sunday 14 June
Welcome Reception (evening)
Monday 15 June
Conference Day 1 & Conference Dinner
Tuesday 16 June
Conference Day 2

Following the success of last year’s inaugural meeting, we are excited to host the second Type I Diabetes Early Detection Summit in Birmingham, UK, on 15–16 June 2026.
This two-day conference is aimed at practising healthcare professionals, doctors, and the wider multidisciplinary team across the UK. The programme will explore both the practicalities and the science underpinning the rapidly evolving field of screening, monitoring, and treatment in early-stage type 1 diabetes (T1D).
With internationally renowned speakers, including Korey Hood (Stanford), Kirsty Bell (Sydney), and Kimber Simmons (Denver), the summit will bring together paediatric and adult diabetes healthcare professionals alongside representatives from key UK organisations and professional societies working across the early type 1 diabetes landscape. Participants will have the opportunity to share ideas, exchange knowledge, and explore research and implementation strategies shaping the emerging field of early T1D.
Case Summary Submission
As part of the programme, we will be running an interactive case discussion session and would like to invite delegates to submit a short clinical case for consideration. Selected cases will be discussed during the summit, with presenters invited to share key insights and learning points with the wider audience.
If you are interested in submitting a case, please complete the submission form here
Please note that all case information must be fully anonymised, with no patient-identifiable data included.
Case Details
If you have any queries relating to this, please contact the Event Management Team at academic.conferences@contacts.bham.ac.uk




As part of the organisation of this conference, the University of Birmingham is collecting income via registration fees and sponsorships on behalf of the Type 1 Diabetes Early Detection Summit 2026 organising committee.
Accessibility Statement